Tech & Innovation • 8 min read

Weaponized Safety: How the FDA Is Killing mRNA

The FDA's refusal to review Moderna's flu vaccine isn't about safety. It is about a retroactive change in math that protects incumbents and drives innovation offshore.

Read Now →
A sterile FDA laboratory with a magnifying glass focusing on a single vial of mRNA vaccine, contrasting with a blurred background of bureaucratic paperwork.

Featured Stories

Tech & Innovation

View all Tech posts →

AI & Automation

Dark data center corridor with hundreds of glowing blue and amber lights on server racks representing autonomous AI agents watching from the shadows

The 80-to-1 Problem: Your AI Agents Are Insider Threats

Enterprises now run 12 AI agents on average, and half operate in total isolation. Machine identities outnumber humans up to 80-to-1, with 44% still authenticating via static API keys. Two landmark reports published on February 5, 2026 reveal an identity governance crisis that mirrors the SaaS sprawl disaster of the 2010s, but this time the ungoverned tools can act autonomously.

View all AI posts →

EVs & Mobility

A split image showing a gleaming BYD showroom in Shanghai with modern EVs on the left, contrasted with an abandoned Detroit auto factory at sunset on the right.

The $80B Capitulation: How Detroit Handed China the Century

Stellantis just wrote off $26 billion, bringing Detroit's cumulative EV losses to over $80 billion. While American automakers retreat to trucks, China sold 13 million EVs in 2025. This is not a correction. It is a surrender that will define the next century of global manufacturing.

View all EV posts →

Energy & Policy

View all Energy posts →

Markets & Money

View all Markets posts →

Picks & Reviews

View all Picks posts →